✦ LIBER ✦

870 A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC)

✍ Scribed by Petrylak, D.; Smith, D.C.; Appleman, L.J.; Fleming, M.; Hussain, A.; Dreicer, R.; Sartor, O.; Shore, N.; Vogelzang, N.; Youssoufian, H.; Stambler, N.; Huang, K.; Israel, R.J.

Book ID: 122977922
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)60857-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP70-20 A PHASE 2 TRIAL OF PROSTATE SPEC

MP70-20 A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)

✍ Petrylak, Daniel; Smith, David C.; Appleman, Leonard J.; Fleming, Mark; Hussain, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 311 KB

244 Prostate Specific Membrane Antigen A

244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

✍ Petrylak, D.; Kantoff, P.; Mega, A.; Stephenson, J.; Vogelzang, N.; Fleming, M.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB